The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CYMABAY THERAPEUTICS, INC. COMMON STOCK 23257D103 19,960 5,905,400 SH   SOLE   5,905,400 0 0
Cogent Biosciences, Inc. COMMON STOCK 19240Q201 23,595 2,750,037 SH   SOLE   2,750,037 0 0
CHINOOK THERAPEUTICS, INC. COMMON STOCK 16961L106 14,391 882,353 SH   SOLE   882,353 0 0
Magenta Therapeutics, Inc. COMMON STOCK 55910K108 9,844 2,222,222 SH   SOLE   2,222,222 0 0
Zai Lab Limited COMMON STOCK 98887Q104 5,971 95,000 SH   SOLE   95,000 0 0
Aclaris Therapeuitics, Inc. COMMON STOCK 00461U105 15,735 1,082,213 SH   SOLE   1,082,213 0 0
Elevation Oncology, Inc. COMMON STOCK 28623U101 3,341 555,000 SH   SOLE   555,000 0 0
Aerovate Therapeutics, Inc. COMMON STOCK 008064107 10,061 853,330 SH   SOLE   853,330 0 0
Iveric Bio, Inc. COMMON STOCK 46583P102 29,113 1,741,228 SH   SOLE   1,741,228 0 0
Viridian Therapeutics Inc COMMON STOCK 92790C104 25,978 1,314,000 SH   SOLE   1,314,000 0 0
Tyra Biosciences, Inc. COMMON STOCK 90240B106 11,966 850,450 SH   SOLE   850,450 0 0
Alpine Immune Sciences, Inc. COMMON STOCK 02083G100 16,207 1,170,212 SH   SOLE   1,170,212 0 0
Akouos, Inc. COMMON STOCK 00973J101 8,884 1,045,215 SH   SOLE   1,045,215 0 0
Merus N.V. COMMON STOCK N5749R100 7,155 225,000 SH   SOLE   225,000 0 0
Entrada Therapeutics, Inc. COMMON STOCK 29384C108 11,362 663,694 SH   SOLE   663,694 0 0